Envoy Medical Corporation
Clinical trials sponsored by Envoy Medical Corporation, explained in plain language.
Envoy Medical Corporation
COCH
NASDAQ
Develops implantable hearing devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Revolutionary fully implanted hearing device tested in adults Results expected Apr 2027 (estimated)